Part of Dana-Farber Cancer Institute and affiliated with Harvard Medical School, the Belfer Institute is built upon a tradition of research excellence and a history of medical innovation. Our scientists are leaders in their fields and our organized and integrated research teams leverage a broad network of research centers of excellence. As a result, we are at the forefront of developing the next generation of cancer therapies. The Belfer Institute recently named two new scientific co-directors and a head of research, adding to its world-class team and continuing to grow its expertise.
In the News
Study reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer